Cargando…
放疗联合免疫治疗对肺癌脑转移的疗效和安全性的meta分析
BACKGROUND AND OBJECTIVE: Immunotherapy (IT) is recommended for the treatment of advanced non-small cell lung cancer (NSCLC), while brain radiotherapy (RT) is the mainstream treatment for patients with brain metastases (BM). This study aimed to investigate the efficacy and safety of combined use of...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619347/ https://www.ncbi.nlm.nih.gov/pubmed/36285391 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.48 |
Ejemplares similares
-
基于增强MRI诊断并行全脑放疗的非小细胞肺癌脑转移预后分析
Publicado: (2011) -
非小细胞肺癌脑转移放疗时机的选择及疗效预后分析
Publicado: (2016) -
立体定向放疗与手术治疗早期NSCLC临床疗效meta分析
Publicado: (2020) -
立体定向放疗治疗15例肺部小肿瘤患者的疗效分析
Publicado: (2011) -
肺癌脑转移生存预测因素分析
Publicado: (2015)